Except known as a gene for cerebral palsy spastic quadriplegia type 218, KANK1 has been reported as a candidate TSG in renal cell carcinoma patients, as it was found that KANK1 re-expression was able to inhibit HEK293 cell growth by reducing proliferation19. This evidence concerns the gene KANK1 and hereditary clear cell renal cell carcinoma.